Marquardt, Jens U.; Vogel, Arndt
Update on systemic therapies for advanced hepatocellular carcinoma (vol 24, pg 711, 2018)ONKOLOGE. Bd. 24. H. 9. 2018 S. 719-719
Marquardt, Jens U.; Vogel, Arndt
Update on systemic therapy of advanced hepatocellular carcinomaONKOLOGE. Bd. 24. H. 9. 2018 S. 711-718
Huber, Yvonne; Bierling, Franziska; Labenz, Christian et al.
Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohortBMC CANCER. Bd. 18. 2018
Franck, S.; Schmidtmann, I.; Heil, E. et al.
Validation of the MESH, HKLC and BCLC classification in a large German cohort of hepatocellular carcinoma patientsJOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S446-S446
Maehringer-Kunz, Aline; Weinmann, Arndt; Schmidtmann, Irene et al.
Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinomaBMC CANCER. Bd. 18. 2018
Gehrke, Nadine; Biedenbach, Jana; Huber, Yvonne et al.
Voluntary Distance Running Prevents Disease Progression in Mice with Non-Alcoholic Fatty Liver Disease (NAFLD).HEPATOLOGY. Bd. 68. 2018 S. 758A-758A
Jansky, M.; Nguyen-Tat, M.; Arslanow, A. et al.
Vorgehen und Zusammenarbeit von Haus- und Fachärzten bei Leberwerterhöhungen - Ergebnisse der Befragungen von Allgemeinmedizinern und Fachärzten mit gastroenterologischem Schwerpunkt in Rheinland-Pfalz und im Saarland.Zeitschrift für Gastroenterologie. Bd. 56. 2018 S. 391
Cook, N. S.; Balp, M.; Chatterjee, S. et al.
WHAT DO PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) VALUE AND NEED? RESULTS FROM A QUANTITATIVE PATIENT PREFERENCE STUDYVALUE IN HEALTH. Bd. 21. 2018 S. S148-S148
Boege, Yannick; Malehmir, Mohsen; Healy, Marc E. et al.
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer DevelopmentCANCER CELL. Bd. 32. H. 3. 2017 S. 342-+
Molokanova, Olena; Hlth, Central I.; Weng, Shih-Yen et al.
A mouse model with inducible ablation of TGFb receptor type 2 limited to hepatic stellate cells predicts the power of HSC-specific TGFb pathway inhibitionHEPATOLOGY. Bd. 66. 2017 S. 234A-235A